Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms
- PMID: 22760445
- PMCID: PMC3432745
- DOI: 10.1007/s11892-012-0302-7
Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms
Abstract
Recent estimates indicate that diabetes mellitus currently affects more than 10 % of the world's population. Evidence from both the laboratory and large scale clinical trials has revealed that prolonged hyperglycemia induces chronic complications which persist and progress unimpeded even when glycemic control is pharmaceutically achieved via the phenomenon of metabolic memory. The epigenome is comprised of all chromatin modifications including post translational histone modification, expression control via miRNAs and the methylation of cytosine within DNA. Modifications of these epigenetic marks not only allow cells and organisms to quickly respond to changing environmental stimuli but also confer the ability of the cell to "memorize" these encounters. As such, these processes have gained much attention as potential molecular mechanisms underlying metabolic memory and chronic diabetic complications. Here we present a review of the very recent literature published pertaining to this subject.
Similar articles
-
Epigenetic changes in diabetes.Clin Genet. 2013 Jul;84(1):1-10. doi: 10.1111/cge.12121. Epub 2013 Mar 11. Clin Genet. 2013. PMID: 23398084 Review.
-
Epigenetic modifications: An important mechanism in diabetic disturbances.Postepy Hig Med Dosw (Online). 2017 Nov 29;71(0):960-974. doi: 10.5604/01.3001.0010.6156. Postepy Hig Med Dosw (Online). 2017. PMID: 29225202 Review.
-
Update: the role of epigenetics in the metabolic memory of diabetic complications.Am J Physiol Renal Physiol. 2024 Sep 1;327(3):F327-F339. doi: 10.1152/ajprenal.00115.2024. Epub 2024 Jul 4. Am J Physiol Renal Physiol. 2024. PMID: 38961840 Review.
-
The epigenetic regulation of podocyte function in diabetes.J Diabetes Complications. 2015 Nov-Dec;29(8):1337-44. doi: 10.1016/j.jdiacomp.2015.07.015. Epub 2015 Jul 17. J Diabetes Complications. 2015. PMID: 26344726 Review.
-
Epigenetic mechanisms in diabetic complications and metabolic memory.Diabetologia. 2015 Mar;58(3):443-55. doi: 10.1007/s00125-014-3462-y. Epub 2014 Dec 7. Diabetologia. 2015. PMID: 25481708 Free PMC article. Review.
Cited by
-
Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.Pathog Dis. 2015 Apr;73(3):ftv002. doi: 10.1093/femspd/ftv002. Epub 2015 Feb 5. Pathog Dis. 2015. PMID: 25663347 Free PMC article.
-
Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus.Front Endocrinol (Lausanne). 2022 Jun 29;13:896511. doi: 10.3389/fendo.2022.896511. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846305 Free PMC article.
-
Trends and Hot Spots of Macrophages Linked to Metabolic Syndrome: A Comprehensive Bibliometric and Visualization Analysis (2014-2024).Mediators Inflamm. 2025 May 24;2025:9487093. doi: 10.1155/mi/9487093. eCollection 2025. Mediators Inflamm. 2025. PMID: 40453651 Free PMC article. Review.
-
Fibroblasts in Diabetic Foot Ulcers.Int J Mol Sci. 2024 Feb 11;25(4):2172. doi: 10.3390/ijms25042172. Int J Mol Sci. 2024. PMID: 38396848 Free PMC article. Review.
-
LncRNA HCG27 Promotes Glucose Uptake Ability of HUVECs by MiR-378a-3p/MAPK1 Pathway.Curr Med Sci. 2023 Aug;43(4):784-793. doi: 10.1007/s11596-023-2738-1. Epub 2023 Jul 5. Curr Med Sci. 2023. PMID: 37405607
References
-
- Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14. - PubMed
-
-
Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625. This manuscript summarizes many years of work and documented a unifying mechanism that causes diabetic complications.
-
-
- Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40(4):405–412. - PubMed
-
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med. 1993;329(14):977–986.
-
-
- Turner RC, Cull CA, Frighi V, Holman RR, UK Prospective Diabetes Study (UKPDS) Group Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) JAMA. 1999;281(21):2005–2012. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials